{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibegnvl7lyapumzfhh4omosrrxgd56qp7i655oaktejkyauqksck4",
    "uri": "at://did:plc:z4547lu5ykj2ot3no6fwz5n4/app.bsky.feed.post/3mgn5nsi5jnu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifvmdhubnw4l45buwrlwanzp2bvsm4vqqlwg5zbo2k3pnzjpiuozy"
    },
    "mimeType": "image/jpeg",
    "size": 38462
  },
  "path": "/article/news/nation-world/hims-hers-stop-selling-compound-glp-1-settle-lawsuit-wegovy/507-f40f2c06-47df-4eb4-a641-891030a4bb74",
  "publishedAt": "2026-03-09T14:49:29.000Z",
  "site": "https://www.wnep.com",
  "tags": [
    "nation-world",
    "news",
    "cct-tracking",
    "syndication",
    "associatedpress"
  ],
  "textContent": "The platforms agreed to stop selling compound versions of Novo Nordisk's Wegovy and instead entered into a collaboration with the health company.",
  "title": "Hims & Hers Health will stop selling compound GLP-1 to settle lawsuit"
}